Bellicum Pharmaceuticals Inc (BLCM) stock has fallen -57.67% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives BLCM stock a score of 18 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 1. BLCM's rank also includes a long-term technical score of 1. The fundamental score for BLCM is 53. In addition to the average rating from Wall Street analysts, BLCM stock has a mean target price of 4.5. This means analysts expect the stock to increase 20.00% over the next 12 months.
What's Happening with BLCM Stock Today
Bellicum Pharmaceuticals Inc (BLCM) stock is trading at $3.75 as of 12:15 PM on Thursday, Mar 4, a decline of -$0.10, or -2.6% from the previous closing price of $3.85. The stock has traded between $3.75 and $4.45 so far today. Volume today is 917,734 compared to average volume of 1,217,952.
Click Here to get the full Stock Score Report on Bellicum Pharmaceuticals Inc (BLCM) Stock.